We collected information about Syntimmune Inc Hours for you. Follow the liks to find out everything about Syntimmune Inc Hours.
SystImmune. Located in Redmond WA, founded in 2014, SystImmune Inc. is a biopharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug …
https://www.yellowpages.com/boston-ma/mip/syntimmune-inc-546611028
Get reviews, hours, directions, coupons and more for Syntimmune, Inc. at 116 Huntington Ave Ste 300, Boston, MA 02116. Search for other Medical Labs in Boston on The Real Yellow Pages®. Browse
https://systimmune.com/contact.html
Social. © 2019 SystImmune Inc. All rights reserved.
https://www.bbb.org/us/ma/boston/profile/medical-lab/syntimmune-inc-0021-465470
Business Profile for Syntimmune, Inc. Medical Lab. Business Profile. Syntimmune, Inc. 116 Huntington Ave # 300. ... Inc., separately incorporated Better Business Bureau organizations in the US ...
https://craft.co/syntimmune
Alexion Pharmaceuticals Inc. announced Wednesday an agreement to buy Syntimmune for a total value of up to $1.2 billion. Syntimmune is a clinical-stage biotechnology company, which currently has a treatment for autoimmune hemolytic anemia being evaluated in phase 1b/2a studies.
https://pitchbook.com/profiles/company/99724-78
Syntimmune General Information Description. Operator is a clinical-stage biotechnology platform designed to develop differentiated drug candidates in a wide range of autoimmune diseases. The company's platform leverages a deep understanding of FcRn biology to develop transformative therapies for patients with autoimmune diseases, enabling ...
https://www.bloomberg.com/profile/company/1391608D:US
Syntimmune, Inc. operates as a biotechnology company. The Company develops therapies for inflammatory diseases and life-threatening toxicities. Syntimmune serves customers in the United States.
https://www.synimmune.de/welcome/
SYNIMMUNE GmbH is a biotechnology company dedicated to the development of innovative and effective mono- and bispecific anti-tumor antibodies for the treatment of patients suffering from life-threatening diseases, with a focus on orphan hematopoietic malignancies. SYNIMMUNE’s lead product candidate is the antibody FLYSYN, which is currently ...
Searching for Syntimmune Inc Hours?
You can just click the links above. The info is collected for you.
